Skip to main content
Clinical Trials/NCT05243901
NCT05243901CompletedNot Applicable

EPIPAGE2 Cohort Study Follow up at Ten and a Half Years

Institut National de la Santé Et de la Recherche Médicale, France1 site in 1 country2,383 target enrollmentStarted: February 17, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
2,383
Locations
1
Primary Endpoint
Factors influencing the child's fitness and motor skills

Study Overview

Brief Summary

Epipage 2 (Epidemiological study on small gestational ages) is a prospective population-based national cohort implemented to better understand the short, mid and long term future of premature children.

This study was launched on 28 March 2011 by the researchers of the EPOPé team (Perinatal, Obstetric and Pediatric Epidemiology Research) of the Epidemiology and Biostatistics Research Centre (INSERM U1153), in collaboration with the Inserm 1027 Unit (Epidemiology and Analysis in Public Health: risks, chronic diseases and handicaps) and medical teams of public health and research in 25 French regions.

The study focuses on children born before 35 weeks of amenorrhea.

3 follow-up steps for children included in the cohort have already been completed at 1, 2 and 5 and a half years of age. Currently, nearly 4,000 children are still eligible for follow-up.

Since the children are 9 years old, the follow-up steps are shared with those set up in another birth cohort, the Elfe cohort (Étude Longitudinale Française depuis l'Enfance, (www.elfe-france.fr) ), as part of the RE-CO-NAI project.

The RE-CO-NAI project is a research platform on cohorts of children followed since birth in order to be able to study in a global and multidisciplinary way the major issues of the health, development and socialization of children.

This RE-CO-NAI project was funded by the EQUIPEX 2011 call for projects as part of future investments.

This protocol, which is part of the RECONAI project, concerns the fully shared follow-up phase, proposed in the 10th year for the children of the two cohorts.

Detailed Description

The objectives of this new follow-up phase are to study:

  • the relationships between prematurity, early growth and cardiometabolic disorders
  • the relationship between parenting educational skills and children's quality of life
  • the factors influencing children's puberty development
  • the factors influencing the child's fitness and motor skills

Study design:

The 10 and a half year follow-up phase is a Category 2 Human Person Research (IHRP 2).

Study population The study population corresponds to all children who have participated in the Epipage 2 cohort since birth and whose parents did not wish to stop follow-up in the study. In total, nearly 4,000 children will be invited to participate in this new follow-up phase.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
10 Years to 11 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children initially included in the Epipage 2 study,
  • Not lost to follow up (i.e. having participated in at least one of the Epipage 2 surveys since the age of 1 year),
  • Neither parent has expressed a definitive refusal to participate in the follow-up study.

Exclusion Criteria

  • Refusal of the investigation by one of the two parents or holders of parental authority,
  • Residence abroad

Outcomes

Primary Outcomes

Factors influencing the child's fitness and motor skills

Time Frame: 10 years and a half

Children's Endurance and Motor Ability Test Results upper or equal to 75th percentile of distribution for sex

Relationships between prematurity, early growth and cardiometabolic disorders

Time Frame: 10 years and a half

Different cardiometabolic parameters will be studied (90th percentile waist for age and sex, 90th percentile systolic or diastolic pressure for age and sex)

Factors influencing children's puberty development

Time Frame: 10 years and a half

Tanner stage

Relationship between parenting educational skills and children's quality of life

Time Frame: 10 years and a half

VSPA scale (Adolescent Experience and Perceived Health)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

EPIPAGE 2 - 10-year Follow-up (RECONAI... | Clinical Trial